The debate over the safety of the world’s most popular weedkiller rages on, and it’s becoming a thorn in the side of the European Food Safety Agency.
Members of the European Parliament this week raised questions about EFSA’s finding that glyphosate, the main ingredient in Monsanto’s Roundup, is unlikely to cause cancer. The EU marketing authorisation of the herbicide is set to expire at the end of the year, and a decision over whether to extend it is pending.
During the plenary session in Brussels on Tuesday (June 13), lawmakers left and right complained that some of the studies used by the agency to make up its mind were commissioned by the chemical industry – the companies selling the herbicides in the first place.
Also this week, an NGO calling for greater corporate transparency issued new research claiming that nearly half – 46 percent – of EFSA’s experts had financial conflicts of interest with the agribusiness and food industries.
EFSA called the figures misleading and said it had been diligent in its review of glyphosate. EU Commissioner for Health and Food Safety Vytenis Andriukaitis, facing MEPs’ questions, defended the agency’s position.
EFSA’s assessment is at odds with the findings of the International Agency for Research on Cancer, which labeled glyphosate a “probable carcinogen”.
IARC’s classification in March 2015 sparked a political storm over whether to re-license or ban sales across the European Union of pesticides containing glyphosate. A decision has yet to be reached, but in the meantime, some countries including France have tightened restrictions on the use of glyphosate in public parks and private gardens.